USTEKID Trial
Trial of a new medication in people with Type 1 diabetes aged 12-18 and within 100 days of diagnosis.
Mahn’s story: Taking Part in Immunotherapy Research
An 11 year old’s story of taking part in immunotherapy research.
News
Our Partners
The consortium is funded by DUK and JDRF with a network of partners.